492PFeasibility of rebiopsy and sequential treatment of...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

492PFeasibility of rebiopsy and sequential treatment of EGFR tyrosine kinase inhibitors in real world patients with EGFR mutant non-small cell lung cancer

Ahn, H, Kim, Y, Kim, E Y, Kim, K W, Sung, K H, Cho, E K, Kang, S M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz437.018
Date:
November, 2019
File:
PDF, 69 KB
2019
Conversion to is in progress
Conversion to is failed